Abstract

This study evaluates the potential of near-infrared Raman spectroscopy for <i>in vivo</i> detection of squamous dysplasia, a precursor to cervical cancer. A pilot clinical trial was carried out at three clinical sites. Raman spectra were measured from one colposcopically normal and one abnormal area of the cervix. These sites were then biopsied and submitted for routine histologic analysis. Twenty-four evaluable measurements were made <i>in vivo</i> in 13 patients. Cervical tissue Raman spectra contain peaks in the vicinity of 1070, 1180, 1195, 1210, 1245, 1330, 1400, 1454, 1505, 1555, 1656, and 1760 cm<sup>-1</sup>. The ratio of intensities at 1454 to 1656 cm<sup>-1</sup> is greater for squamous dysplasia than all other tissue types, while the ratio of intensities at 1330 to 1454 cm<sup>-1</sup> is lower for samples with squamous dysplasia than all other tissue types. A simple algorithm based on these two intensity ratios separates high-grade squamous dysplasia from all others, misclassifying only one sample. Spectra measured <i>in vivo</i> resemble those measured <i>in vitro</i>. Cervical epithelial cells may contribute to tissue spectra at 1330 cm<sup>-1</sup>, a region associated with DNA. In contrast, epithelial cells probably do not contribute to tissue spectra at 1454 cm<sup>-1</sup>, a region associated with collagen and phospholipids.

PDF Article

Cited By

You do not have subscription access to this journal. Cited by links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access OSA Member Subscription